Compare Agilent Technologies Inc (A) vs iShares MSCI China ETF (MCHI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs iShares MSCI China ETF — how do they compare? Agilent Technologies Inc trades at $128.45 (market cap $37.04B), while iShares MSCI China ETF trades at $52.77. The key difference: Agilent Technologies Inc pays a 0.78% dividend while iShares MSCI China ETF pays none, and Agilent Technologies Inc is trading nearer its 52-week high, iShares MSCI China ETF nearer its low. Which is the better fit depends on your goals.
| A | MCHI | |
|---|---|---|
Market Cap | $37.04B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $157.20 | $66.99 |
52-Week Low | $110.24 | $50.48 |
Enterprise Value | $38.59B | — |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
MCHI trades at $52.02, up 2.18% today, amid a bearish technical signal with moving averages indicating selling pressure and oscillators neutral. The stock faces resistance at $52. Recent news highlights China's AI and export-driven factory rebound, which could benefit broad China ETFs like MCHI, but structural headwinds and value trap risks persist according to some analysts.
The outlook remains cautious due to mixed technicals and macroeconomic uncertainties. Opportunities exist if China's tech and manufacturing recovery accelerates, but risks include U.S.-China tensions, deflationary pressures, and potential regulatory changes. Investors should weigh the ETF's exposure to China's cyclical sectors against its attractive valuation multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About iShares MSCI China ETF
MCHI is an ETF that seeks to track the investment results of the MSCI China Index. It provides broad exposure to the Chinese equity market, primarily focusing on large and mid-cap companies listed in Hong Kong and Shanghai. MCHI serves as a core holding for investors looking to gain diversified exposure to the performance and growth potential of the companies within the People's Republic of China.
Read more on MCHI →
